Spike Suppressors
Spike Suppressors market is segmented by region (country), players, by Type and by Application. P ... Read More
Global and United States Antivenin Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Antivenin Product Introduction
1.2 Global Antivenin Outlook 2017 VS 2022 VS 2028
1.2.1 Global Antivenin Sales in US$ Million for the Year 2017-2028
1.2.2 Global Antivenin Sales in Volume for the Year 2017-2028
1.3 United States Antivenin Outlook 2017 VS 2022 VS 2028
1.3.1 United States Antivenin Sales in US$ Million for the Year 2017-2028
1.3.2 United States Antivenin Sales in Volume for the Year 2017-2028
1.4 Antivenin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Antivenin in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Antivenin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Antivenin Market Dynamics
1.5.1 Antivenin Industry Trends
1.5.2 Antivenin Market Drivers
1.5.3 Antivenin Market Challenges
1.5.4 Antivenin Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Antivenin Market Segment by Type
2.1.1 Polyvalent
2.1.2 Monovalent
2.2 Global Antivenin Market Size by Type
2.2.1 Global Antivenin Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Antivenin Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Antivenin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Antivenin Market Size by Type
2.3.1 United States Antivenin Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Antivenin Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Antivenin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Antivenin Market Segment by Application
3.1.1 Hospitals and Clinics
3.1.2 Non-profit Institutions
3.2 Global Antivenin Market Size by Application
3.2.1 Global Antivenin Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Antivenin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Antivenin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Antivenin Market Size by Application
3.3.1 United States Antivenin Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Antivenin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Antivenin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Antivenin Competitor Landscape by Company
4.1 Global Antivenin Market Size by Company
4.1.1 Top Global Antivenin Manufacturers Ranked by Revenue (2021)
4.1.2 Global Antivenin Revenue by Manufacturer (2017-2022)
4.1.3 Global Antivenin Sales by Manufacturer (2017-2022)
4.1.4 Global Antivenin Price by Manufacturer (2017-2022)
4.2 Global Antivenin Concentration Ratio (CR)
4.2.1 Antivenin Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antivenin in 2021
4.2.3 Global Antivenin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Antivenin Manufacturing Base Distribution, Product Type
4.3.1 Global Antivenin Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Antivenin Product Type
4.3.3 Date of International Manufacturers Enter into Antivenin Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Antivenin Market Size by Company
4.5.1 Top Antivenin Players in United States, Ranked by Revenue (2021)
4.5.2 United States Antivenin Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Antivenin Sales by Players (2020, 2021 & 2022)
5 Global Antivenin Market Size by Region
5.1 Global Antivenin Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Antivenin Market Size in Volume by Region (2017-2028)
5.2.1 Global Antivenin Sales in Volume by Region: 2017-2022
5.2.2 Global Antivenin Sales in Volume Forecast by Region (2023-2028)
5.3 Global Antivenin Market Size in Value by Region (2017-2028)
5.3.1 Global Antivenin Sales in Value by Region: 2017-2022
5.3.2 Global Antivenin Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Antivenin Market Size YoY Growth 2017-2028
6.1.2 North America Antivenin Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Antivenin Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Antivenin Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Antivenin Market Size YoY Growth 2017-2028
6.3.2 Europe Antivenin Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Antivenin Market Size YoY Growth 2017-2028
6.4.2 Latin America Antivenin Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Antivenin Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Antivenin Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 CSL
7.1.1 CSL Corporation Information
7.1.2 CSL Description and Business Overview
7.1.3 CSL Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CSL Antivenin Products Offered
7.1.5 CSL Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Antivenin Products Offered
7.2.5 Merck Recent Development
7.3 BTG
7.3.1 BTG Corporation Information
7.3.2 BTG Description and Business Overview
7.3.3 BTG Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.3.4 BTG Antivenin Products Offered
7.3.5 BTG Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Antivenin Products Offered
7.4.5 Pfizer Recent Development
7.5 Haffkine Bio-Pharmaceutical
7.5.1 Haffkine Bio-Pharmaceutical Corporation Information
7.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
7.5.3 Haffkine Bio-Pharmaceutical Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Haffkine Bio-Pharmaceutical Antivenin Products Offered
7.5.5 Haffkine Bio-Pharmaceutical Recent Development
7.6 Rare Disease Therapeutics
7.6.1 Rare Disease Therapeutics Corporation Information
7.6.2 Rare Disease Therapeutics Description and Business Overview
7.6.3 Rare Disease Therapeutics Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Rare Disease Therapeutics Antivenin Products Offered
7.6.5 Rare Disease Therapeutics Recent Development
7.7 Flynn Pharma
7.7.1 Flynn Pharma Corporation Information
7.7.2 Flynn Pharma Description and Business Overview
7.7.3 Flynn Pharma Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Flynn Pharma Antivenin Products Offered
7.7.5 Flynn Pharma Recent Development
7.8 Vins Bioproducts
7.8.1 Vins Bioproducts Corporation Information
7.8.2 Vins Bioproducts Description and Business Overview
7.8.3 Vins Bioproducts Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Vins Bioproducts Antivenin Products Offered
7.8.5 Vins Bioproducts Recent Development
7.9 Bharat Serums and Vaccines
7.9.1 Bharat Serums and Vaccines Corporation Information
7.9.2 Bharat Serums and Vaccines Description and Business Overview
7.9.3 Bharat Serums and Vaccines Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bharat Serums and Vaccines Antivenin Products Offered
7.9.5 Bharat Serums and Vaccines Recent Development
7.10 Serum Biotech
7.10.1 Serum Biotech Corporation Information
7.10.2 Serum Biotech Description and Business Overview
7.10.3 Serum Biotech Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Serum Biotech Antivenin Products Offered
7.10.5 Serum Biotech Recent Development
7.11 MicroPharm
7.11.1 MicroPharm Corporation Information
7.11.2 MicroPharm Description and Business Overview
7.11.3 MicroPharm Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.11.4 MicroPharm Antivenin Products Offered
7.11.5 MicroPharm Recent Development
7.12 CSL
7.12.1 CSL Corporation Information
7.12.2 CSL Description and Business Overview
7.12.3 CSL Antivenin Sales, Revenue and Gross Margin (2017-2022)
7.12.4 CSL Products Offered
7.12.5 CSL Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Antivenin Industry Chain Analysis
8.2 Antivenin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Antivenin Distributors
8.3 Antivenin Production Mode & Process
8.4 Antivenin Sales and Marketing
8.4.1 Antivenin Sales Channels
8.4.2 Antivenin Distributors
8.5 Antivenin Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Antivenin CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Antivenin Market Trends
Table 3. Antivenin Market Drivers
Table 4. Antivenin Market Challenges
Table 5. Antivenin Market Restraints
Table 6. Global Antivenin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Antivenin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Antivenin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Antivenin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Antivenin Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Antivenin Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Antivenin Revenue Share by Manufacturer, 2017-2022
Table 13. Global Antivenin Sales by Manufacturer, (K Vials), 2017-2022
Table 14. Global Antivenin Sales Share by Manufacturer, 2017-2022
Table 15. Global Antivenin Price by Manufacturer (2017-2022) & (USD/Vial)
Table 16. Global Antivenin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Antivenin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivenin as of 2021)
Table 18. Top Players of Antivenin in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Antivenin Product Type
Table 20. Date of International Manufacturers Enter into Antivenin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Antivenin Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Antivenin Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Antivenin Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Antivenin Sales by Players, (K Vials), 2020, 2021 & 2022
Table 26. United States Antivenin Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Antivenin Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Antivenin Sales in Volume by Region (2017-2022) & (K Vials)
Table 29. Global Antivenin Sales in Volume Forecast by Region (2023-2028) & (K Vials)
Table 30. Global Antivenin Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Antivenin Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Antivenin Sales in Volume by Country (2017-2028) & (K Vials)
Table 33. North America Antivenin Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Antivenin Sales in Volume by Region (2017-2028) & (K Vials)
Table 35. Asia Pacific Antivenin Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Antivenin Sales in Volume by Country (2017-2028) & (K Vials)
Table 37. Europe Antivenin Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Antivenin Sales in Volume by Country (2017-2028) & (K Vials)
Table 39. Latin Americaa Antivenin Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Antivenin Sales in Volume by Country (2017-2028) & (K Vials)
Table 41. Middle East and Africa Antivenin Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. CSL Corporation Information
Table 43. CSL Description and Business Overview
Table 44. CSL Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 45. CSL Antivenin Product
Table 46. CSL Recent Development
Table 47. Merck Corporation Information
Table 48. Merck Description and Business Overview
Table 49. Merck Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 50. Merck Product
Table 51. Merck Recent Development
Table 52. BTG Corporation Information
Table 53. BTG Description and Business Overview
Table 54. BTG Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 55. BTG Product
Table 56. BTG Recent Development
Table 57. Pfizer Corporation Information
Table 58. Pfizer Description and Business Overview
Table 59. Pfizer Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 60. Pfizer Product
Table 61. Pfizer Recent Development
Table 62. Haffkine Bio-Pharmaceutical Corporation Information
Table 63. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 64. Haffkine Bio-Pharmaceutical Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 65. Haffkine Bio-Pharmaceutical Product
Table 66. Haffkine Bio-Pharmaceutical Recent Development
Table 67. Rare Disease Therapeutics Corporation Information
Table 68. Rare Disease Therapeutics Description and Business Overview
Table 69. Rare Disease Therapeutics Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 70. Rare Disease Therapeutics Product
Table 71. Rare Disease Therapeutics Recent Development
Table 72. Flynn Pharma Corporation Information
Table 73. Flynn Pharma Description and Business Overview
Table 74. Flynn Pharma Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 75. Flynn Pharma Product
Table 76. Flynn Pharma Recent Development
Table 77. Vins Bioproducts Corporation Information
Table 78. Vins Bioproducts Description and Business Overview
Table 79. Vins Bioproducts Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 80. Vins Bioproducts Product
Table 81. Vins Bioproducts Recent Development
Table 82. Bharat Serums and Vaccines Corporation Information
Table 83. Bharat Serums and Vaccines Description and Business Overview
Table 84. Bharat Serums and Vaccines Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 85. Bharat Serums and Vaccines Product
Table 86. Bharat Serums and Vaccines Recent Development
Table 87. Serum Biotech Corporation Information
Table 88. Serum Biotech Description and Business Overview
Table 89. Serum Biotech Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 90. Serum Biotech Product
Table 91. Serum Biotech Recent Development
Table 92. MicroPharm Corporation Information
Table 93. MicroPharm Description and Business Overview
Table 94. MicroPharm Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 95. MicroPharm Product
Table 96. MicroPharm Recent Development
Table 97. CSL Corporation Information
Table 98. CSL Description and Business Overview
Table 99. CSL Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022)
Table 100. CSL Product
Table 101. CSL Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Antivenin Customers List
Table 105. Antivenin Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenin Product Picture
Figure 2. Global Antivenin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Antivenin Market Size 2017-2028 (US$ Million)
Figure 4. Global Antivenin Sales 2017-2028 (K Vials)
Figure 5. United States Antivenin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Antivenin Market Size 2017-2028 (US$ Million)
Figure 7. United States Antivenin Sales 2017-2028 (K Vials)
Figure 8. United States Antivenin Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Antivenin Market Share in Global, in Volume (K Vials) 2017-2028
Figure 10. Antivenin Report Years Considered
Figure 11. Product Picture of Polyvalent
Figure 12. Product Picture of Monovalent
Figure 13. Global Antivenin Market Share by Type in 2022 & 2028
Figure 14. Global Antivenin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Antivenin Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Antivenin Sales by Type (2017-2028) & (K Vials)
Figure 17. Global Antivenin Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Antivenin Price by Type (2017-2028) & (USD/Vial)
Figure 19. United States Antivenin Market Share by Type in 2022 & 2028
Figure 20. United States Antivenin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Antivenin Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Antivenin Sales by Type (2017-2028) & (K Vials)
Figure 23. United States Antivenin Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Antivenin Price by Type (2017-2028) & (USD/Vial)
Figure 25. Product Picture of Hospitals and Clinics
Figure 26. Product Picture of Non-profit Institutions
Figure 27. Global Antivenin Market Share by Application in 2022 & 2028
Figure 28. Global Antivenin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Antivenin Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Antivenin Sales by Application (2017-2028) & (K Vials)
Figure 31. Global Antivenin Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Antivenin Price by Application (2017-2028) & (USD/Vial)
Figure 33. United States Antivenin Market Share by Application in 2022 & 2028
Figure 34. United States Antivenin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Antivenin Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Antivenin Sales by Application (2017-2028) & (K Vials)
Figure 37. United States Antivenin Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Antivenin Price by Application (2017-2028) & (USD/Vial)
Figure 39. North America Antivenin Sales in Volume Growth Rate 2017-2028 (K Vials)
Figure 40. North America Antivenin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. United States Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Antivenin Sales in Volume Growth Rate 2017-2028 (K Vials)
Figure 44. Europe Antivenin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Antivenin Sales in Volume Growth Rate 2017-2028 (K Vials)
Figure 51. Asia-Pacific Antivenin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. China Taiwan Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Latin America Antivenin Sales in Volume Growth Rate 2017-2028 (K Vials)
Figure 62. Latin America Antivenin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 63. Mexico Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Brazil Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Argentina Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Middle East & Africa Antivenin Sales in Volume Growth Rate 2017-2028 (K Vials)
Figure 67. Middle East & Africa Antivenin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Turkey Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Saudi Arabia Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. UAE Antivenin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Antivenin Value Chain
Figure 72. Antivenin Production Process
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Merck BTG Pfizer Haffkine Bio-Pharmaceutical Rare Disease Therapeutics Flynn Pharma Vins Bioproducts Bharat Serums and Vaccines Serum Biotech MicroPharm CSL